Fig. 7.
Effect of bimatoprost (Bim) and prostaglandin F2α ethanolamide (PGF2αEA) on the inhibition of 3T3-L1 cell proliferation by rosiglitazone (Rosi). 3T3-L1 preadipocytes were untreated or treated with DMSO (0.1%), Bim (0.05 μM; A)/PGF2αEA (0.05 μM; B), or Rosi (0.5 μM) without or with Bim or PGF2αEA, for four days. Cell viability was quantified with the MTT assay. The results are presented as percentages relative to the untreated control and are shown as the mean ± SD of four (A) or three (B) independent bioreplicates. ∗P < 0.05, ∗∗P < 0.01. MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.